View Author
patient artery group study disease stent treatment outcome trial angioplasty restenosi intervention percutaneou analysis table artery disease syntax revascularization lumen month stenosi infarction result event score lesion follow-up death vessel value occlusion surgery cardiol circulation difference tranilast cardiogenic shock heart smoker angiographic baseline procedure smoking bifurcation neointimal stenting figure syntax score 1 year point change smoking status placebo <0ยท001 mortality effect angle diameter macce neointima country angiography shock pci group status lm disease cardiogenic plaque frequency 30- day mortality drug-eluting stents drug-eluting article randomized therapy cerebrovascular events hospital comparison end point angina
10 Most Recent Publications
|
Analysis of Stroke Occurring in the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Trial Comparing Coronary Artery Bypass Surgery and Percutaneous Coronary Intervention in the Treatment of Complex Coronary Artery Disease
(Article)
Mack, M.J. Head, S.J. Dawkins, K.D. Serruys, P.W.J.C. Mohr, F.W. Kappetein, A.P. Holmes Jr, D.R. Stahle, E. Feldman, T.E. Colombo, A. Morice, M-C. Unger, F. Erglis, A. Stoler, R. |
2013-03-21
|
|
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial
(Article)
Morice, M-C. Serruys, P.W.J.C. Leadley, K. Dawkins, K.D. Mohr, F.W. Kappetein, A.P. Feldman, T.E. Stahle, E. Colombo, A. Mack, M.J. Holmes Jr, D.R. Torracca, L. Es, G.A. van |
2010-06-22
|
|
3-Dimensional Bifurcation Angle Analysis in Patients With Left Main Disease. A Substudy of the SYNTAX Trial (SYNergy Between Percutaneous Coronary Intervention With TAXus and Cardiac Surgery)
(Article)
Girasis, C. Serruys, P.W.J.C. Onuma, Y. Colombo, A. Holmes Jr, D.R. Feldman, T.E. Bass, E.J. Leadley, K. Dawkins, K.D. Morice, M-C. |
2010-01-01
|
|
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
(Article)
Serruys, P.W.J.C. Morice, M-C. Dyck, N. van Leadley, K. Dawkins, K.D. Mohr, F.W. Kappetein, A.P. Colombo, A. Holmes Jr, D.R. Mack, M.J. Stahle, E. Feldman, T.E. Brand, M.J.B.M. van den Bass, E.J. |
2009-03-05
|
|
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial
(Article)
Holmes Jr, D.R. Granett, J.R. Davis, B.R. Poland, M. Zeiher, A.M. Willerson, J.T. King 3rd, S.B. Shapiro, L.M. Savage, M. Lablanche, J.M. Tcheng, J.E. Grip, L. Popma, J.J. Serruys, P.W.J.C. Fitzgerald, P.J. Fischman, D. Ferguson, J.J. Lincoff, A.M. Goldberg, S. Brinker, J.A. Chan, R. |
2002-01-01
|
|
Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: Effect of inhibition of platelet glycoprotoin IIb/IIIa with eptifibatide
(Article)
Hasdai, D. Holmes Jr, D.R. Criger, D.A. Topol, E.J. Califf, R.M. Wilcox, R.G. Paolasso, E. Simoons, M.L. Harrington, R.A. Deckers, J.W. |
2000-01-01
|
|
Artery size, neointima, and remodeling: time for some standards.
(Article)
Schwartz, R.S. Topol, E.J. Serruys, P.W.J.C. Sangiorgi, G. Holmes Jr, D.R. |
1998-12-01
|
|
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial
(Article)
Holmes Jr, D.R. Califf, R.M. Berger, P.B. Bates, E.R. Simoons, M.L. White, H.D. Thompson, T.D. Topol, E.J. Werf, F.J.J. van de |
1997-01-20
|
|
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996.
(Article)
Ellis, S.G. Tamai, H. Teirstein, P.S. Serruys, P.W.J.C. Bittl, J.A. Mooney, M.R. Shimshak, T.M. Block, P.C. Erbel, R. Nobuyoshi, M. Kosuga, K. Colombo, A. Holmes Jr, D.R. Macaya Miguel, C.M. Grines, C.L. Whitlow, P.L. White, H.J. Moses, J. |
1997-01-01
|
|
Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).
(Article)
Berger, P.B. Holmes Jr, D.R. Ohman, E.M. O'Hanesian, M.A. Murphy, J.G. Schwartz, R.S. Serruys, P.W.J.C. Faxon, D.P. |
1996-01-01
|
